This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting (CAS)

This study has been completed.
Information provided by (Responsible Party):
Progyny, Inc. Identifier:
First received: June 8, 2012
Last updated: January 9, 2014
Last verified: January 2014
User questionnaire of Eeva System usability and reports of device malfunctions.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Eeva Continued Access Study.

Further study details as provided by Progyny, Inc.:

Primary Outcome Measures:
  • User questionnaire of Eeva System usability and reports of device malfunctions. [ Time Frame: Participants will be followed through ongoing pregnancy, at approximately 10-12 weeks gestational age. ]

Enrollment: 31
Study Start Date: June 2012
Study Completion Date: February 2013
Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
Women undergoing IVF treatment
Women undergoing IVF treatment

Detailed Description:
This study is designed to evaluate the use of Eeva by IVF laboratory staff during routine procedures. The fertilized eggs will be placed in an Eeva dish and the development of the embryos will be monitored by the Eeva system in a standard incubator. On day 3 of embryo culture, Eeva blastocyst prediction data will be printed from the system to be used to assist the embryologist in selecting the best embryo(s). The performance of the system will be summarized and the user feedback from the embryologists will be collected.

Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Women in the United States who undergo IVF treatment and imaging of their embryos with Eeva.

Inclusion Criteria:

  • Women undergoing fresh in vitro fertilization treatment using their own eggs or donor eggs
  • Subject is ≥ 18 and ≤ 40 years of age.
  • Subject has basal antral follicle count (AFC) ≥ 8 prior to stimulation cycle.
  • Fertilization using only ejaculated sperm (fresh or frozen) - no surgically retrieved sperm.
  • Subject has ≥ 5 normally fertilized eggs (2 PN)
  • Willing to have all 2PN embryos monitored by Eeva
  • Willing to comply with study protocol and procedures and able to speak English.
  • Willing to provide written informed consent.

Exclusion Criteria:

  • Reinseminated eggs.
  • History of cancer.
  • Gestational carriers.
  • Planned preimplantation genetic diagnosis or preimplantation genetic screening.
  • Previously enrolled in this study
  • Concurrent participation in another clinical study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01617993

United States, California
Pacific Fertility Center
San Francisco, California, United States, 94133
Fertility Physicians of Northern California
San Jose, California, United States, 95124
Reproductive Science Center
San Ramon, California, United States, 94583
Sponsors and Collaborators
Progyny, Inc.
Study Director: Shehua Shen, ELD, MD Progyny, Inc.
  More Information

Additional Information:
Responsible Party: Progyny, Inc. Identifier: NCT01617993     History of Changes
Other Study ID Numbers: 2012-AUX-002
Study First Received: June 8, 2012
Last Updated: January 9, 2014

Keywords provided by Progyny, Inc.:
in vitro fertilization
assisted reproduction
noninvasive imaging of embryos
time lapse imaging of embryos
traditional morphological grading of embryos
prediction of blastocysts
Genital Diseases, Male
Genital Diseases, Female

Additional relevant MeSH terms:
Genital Diseases, Male
Genital Diseases, Female processed this record on September 21, 2017